Opportunity Information: Apply for PAR 13 289
Apply for PAR 13 289
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Building Evidence Effective Palliative/End of Life Care Interventions (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.361 Nursing Research.
- This funding opportunity was created on Jul 26, 2013 and posted on Jul 26, 2013.
- Applicants must submit their applications by Jun 9, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Native American tribal governments (Federally recognized) Private institutions of higher education Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses For profit organizations other than small businesses State governments County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled Additional Information on Eligibility for clarification) Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Special district governments City or township governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
Building Evidence Effective Palliative/End of Life Care Interventions (R01) (Funding Opportunity Number PAR-13-289) is a National Institutes of Health (NIH) research grant opportunity designed to build stronger, outcomes-based evidence for palliative care and end-of-life (PCEOL) interventions. The central aim is to stimulate rigorous research that develops, refines, and tests models of care for people living with life-limiting illnesses (LLIs), with an emphasis on using measurable outcomes to determine what works best, for whom, and under what conditions. The announcement reflects the growing demand for high-quality palliative and end-of-life care across many settings and populations, including individuals who are older, culturally diverse, or otherwise underserved, and it underscores that serious illness affects not only patients but also their caregivers and families.
A key motivation behind the FOA is the recognition that many people with LLIs are also managing multiple complex comorbidities (MCCs). This combination can intensify symptom burden, complicate clinical decision-making, increase caregiver strain, and place substantial pressure on health care systems and costs. In that context, the FOA encourages research that does more than describe needs; it pushes applicants to test concrete interventions or care models and evaluate them with clear, trackable outcomes. While the summary text does not list specific endpoints, the framing strongly suggests outcomes relevant to patient and family well-being and health system performance, such as symptom control, quality of life, communication and decision support, care coordination, caregiver outcomes, service utilization, and potentially cost-related measures.
The mechanism is an NIH R01, meaning the program is oriented toward full-scale, hypothesis-driven or well-developed intervention research rather than small pilot efforts. The activity category is listed under Education and Health, and the CFDA number provided is 93.361 (Nursing Research), signaling strong relevance to nursing science and interdisciplinary care delivery research, even though applicants may come from a wide range of disciplines and institutions. There is no cost sharing or matching requirement, which reduces barriers for applicants that might not have discretionary funds to contribute.
Eligibility is broad and intentionally inclusive. Eligible applicants include public and private institutions of higher education; nonprofit organizations both with and without 501(c)(3) status; for-profit entities (including small businesses and other for-profit organizations); state, county, city/township, special district governments; independent school districts; and public housing authorities/Indian housing authorities. The announcement explicitly extends eligibility to a wide range of mission-serving institutions and community-rooted organizations, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based and community-based organizations. Importantly, foreign organizations and foreign institutions are eligible, and non-U.S. components of U.S. organizations may apply; foreign components are also allowed consistent with NIH policy. This wide eligibility aligns with the FOA's emphasis on culturally diverse populations and the reality that palliative care models are implemented across varied systems and communities.
Administratively, the opportunity was posted and created on July 26, 2013, with an original and final closing date of June 9, 2016, and an archive date of July 10, 2016. In other words, this specific FOA is no longer active, but it provides a clear snapshot of NIH priorities during that period around building the evidence base for palliative and end-of-life care interventions using robust outcome measurement. For full details, NIH provided an official FOA link (http://grants.nih.gov/grants/guide/pa-files/PAR-13-289.html) and directed technical access questions to the NIH Office of Extramural Research (OER) webmaster (FBOWebmaster@OD.NIH.GOV).
Frequently Asked Questions (FAQs)
What is the name of this grant opportunity?
The opportunity is titled Building Evidence Effective Palliative/End of Life Care Interventions (R01), with Funding Opportunity Number PAR-13-289.
Which agency is offering this funding opportunity?
This is a National Institutes of Health (NIH) research grant opportunity.
What is the main purpose of PAR-13-289?
The central aim is to build stronger, outcomes-based evidence for palliative care and end-of-life (PCEOL) interventions by stimulating rigorous research that develops, refines, and tests models of care for people living with life-limiting illnesses (LLIs).
What types of projects does the FOA emphasize?
The FOA emphasizes research that goes beyond describing needs and instead tests concrete interventions or care models, evaluating them with measurable, trackable outcomes to determine what works best, for whom, and under what conditions.
What does PCEOL mean in this announcement?
PCEOL refers to palliative care and end-of-life care and related interventions intended to improve care and outcomes for people with serious, life-limiting illness and their families/caregivers.
Who is the target population for the interventions studied under this FOA?
The focus is on people living with life-limiting illnesses, with recognition that serious illness affects not only patients but also their caregivers and families.
Does the FOA highlight any specific populations or equity considerations?
Yes. The announcement reflects demand for high-quality palliative and end-of-life care across many settings and populations, including individuals who are older, culturally diverse, or otherwise underserved.
Why does the FOA discuss multiple complex comorbidities (MCCs)?
The FOA notes that many people with life-limiting illnesses also manage multiple complex comorbidities (MCCs), which can increase symptom burden, complicate decision-making, increase caregiver strain, and create pressure on health systems and costs. This context supports the FOA's push for interventions evaluated with clear outcomes.
What kinds of outcomes are implied by the FOA?
While the summary does not list specific endpoints, it strongly suggests outcomes relevant to patient/family well-being and health system performance, such as symptom control, quality of life, communication and decision support, care coordination, caregiver outcomes, service utilization, and potentially cost-related measures.
What funding mechanism is used?
The mechanism is an NIH R01, indicating a focus on full-scale, well-developed, hypothesis-driven intervention research rather than small pilot projects.
What is the activity category for this opportunity?
The activity category is listed under Education and Health.
What is the CFDA number associated with this opportunity?
The CFDA number provided is 93.361 (Nursing Research), reflecting strong relevance to nursing science and interdisciplinary care delivery research.
Does this FOA require cost sharing or matching funds?
No. The opportunity states there is no cost sharing or matching requirement.
Who is eligible to apply?
Eligibility is broad and includes:
- Public and private institutions of higher education
- Nonprofit organizations (with or without 501(c)(3) status)
- For-profit entities (including small businesses and other for-profit organizations)
- State governments
- County governments
- City/township governments
- Special district governments
- Independent school districts
- Public housing authorities/Indian housing authorities
Are community-based and faith-based organizations eligible?
Yes. The announcement explicitly includes faith-based and community-based organizations among eligible applicant types.
Does the FOA encourage applications from specific institution types?
Yes. It explicitly extends eligibility to mission-serving institutions and community-rooted organizations, including HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, and AANAPISIs.
Are foreign organizations eligible to apply?
Yes. Foreign organizations and foreign institutions are eligible, and non-U.S. components of U.S. organizations may apply. Foreign components are allowed consistent with NIH policy.
Is this funding opportunity currently active?
No. The FOA has been archived. It was posted and created on July 26, 2013, with an original and final closing date of June 9, 2016, and an archive date of July 10, 2016.
Where can applicants find the official FOA details?
NIH provided an official FOA link: http://grants.nih.gov/grants/guide/pa-files/PAR-13-289.html
Who should be contacted for technical access questions about the FOA?
For technical access questions, NIH directed inquiries to the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
What broader need or trend does this FOA respond to?
The announcement reflects a growing demand for high-quality palliative and end-of-life care across many settings and populations, and it underscores that serious illness impacts both patients and the people who care for them.
Does the FOA suggest the research should identify what works for different groups and settings?
Yes. A stated goal is to determine what works best for whom and under what conditions, using measurable outcomes to compare or evaluate models of care.
Browse more opportunities from the same category: Education Health
Next opportunity: Systemic Amyloidosis Basic, Translational, and Clinical Research (R01)
Previous opportunity: Department of Defense Child Care Curriculum
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 13 289
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 13 289) also looked into and applied for these:
| Funding Opportunity |
|---|
| NLM Express Research Grants in Biomedical Informatics (R01) Apply for PAR 13 300 Funding Number: PAR 13 300 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Advanced Development of Informatics Technology (U24) Apply for PAR 13 294 Funding Number: PAR 13 294 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Revisions to P01 Awards for Research on Detection of Pathogen Induced Cancer (DPIC) (P01) Apply for PAR 13 297 Funding Number: PAR 13 297 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Revisions to P50 Awards for Research on Detection of Pathogen Induced Cancer (DPIC) (P50) Apply for PAR 13 298 Funding Number: PAR 13 298 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Revision Applications to P01 Awards for Research on Imaging and Biomarkers for Early Cancer Detection (P01) Apply for PAR 13 317 Funding Number: PAR 13 317 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Revision Applications to P50 Awards for Research on Imaging and Biomarkers for Early Cancer Detection (P50) Apply for PAR 13 318 Funding Number: PAR 13 318 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| National Cancer Institute Program Project Applications (P01) Apply for PAR 13 321 Funding Number: PAR 13 321 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Increased Knowledge and Innovative Strategies to Reduce HIV IncidenceiKnow Projects (R01) Apply for PAR 13 323 Funding Number: PAR 13 323 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (SBIR R43/44) Apply for PAR 13 327 Funding Number: PAR 13 327 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Revisions for Early Stage Development of Informatics Technology (P01) Apply for PAR 13 330 Funding Number: PAR 13 330 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Health Promotion Among Racial and Ethnic Minority Males (R21) Apply for PA 13 331 Funding Number: PA 13 331 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01) Apply for PAR 13 334 Funding Number: PAR 13 334 Agency: National Institutes of Health Category: Education Health Funding Amount: $3,000,000 |
| Neuroscience Research on Drug Abuse (R21) Apply for PA 13 337 Funding Number: PA 13 337 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Neuroscience Research on Drug Abuse (R03) Apply for PA 13 336 Funding Number: PA 13 336 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Neuroscience Research on Drug Abuse (R01) Apply for PA 13 338 Funding Number: PA 13 338 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mechanisms of Alcohol and Stimulant Co Addiction (R01) Apply for PA 13 339 Funding Number: PA 13 339 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mechanisms of Alcohol and Stimulant Co Addiction (R21) Apply for PA 13 340 Funding Number: PA 13 340 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Early Career Award in Chemistry of Drug Abuse and Addiction (ECHEM) (R21/R33) Apply for PAR 13 350 Funding Number: PAR 13 350 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| National Institute on Drug Abuse National Early Warning System (NEWS) Coordinating Center (U01) Apply for RFA DA 14 015 Funding Number: RFA DA 14 015 Agency: National Institutes of Health Category: Education Health Funding Amount: $900,000 |
| Research Answers to NCIs Provocative Questions Group A (R01) Apply for RFA CA 13 016 Funding Number: RFA CA 13 016 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 13 289", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.